Meniru G I, Gorgy A, Batha S, Clarke R J, Podsiadly B T, Craft I L
London Gynaecology and Fertility Centre, UK.
Hum Reprod Update. 1998 Jan-Feb;4(1):57-71. doi: 10.1093/humupd/4.1.57.
Four distinct studies were carried out using two data sets of percutaneous epididymal sperm aspiration (PESA) and intracytoplasmic sperm injection (ICSI) procedures performed from March 1993 to January 1997. In study A, an analysis of 181 ICSI treatment cycles following PESA revealed a successful epididymal sperm retrieval rate of 83%. It confirmed that PESA is an effective sperm retrieval method and the associated ICSI pregnancy rate (35% per embryo transfer) compared favourably with that of other sperm retrieval methods. In study B, the relevance of a prior diagnostic PESA procedure was ascertained by comparing the sperm retrieval rates in two groups of patients having their first ICSI treatment cycle with spermatozoa retrieved through PESA. Group B1 (n = 50) had diagnostic PESA prior to the ICSI treatment cycle PESA procedure, unlike patients in group B2 (n = 64) who did not. The sperm retrieval rate in the treatment cycle procedure was not different at 90 and 82.8% for groups B1 and B2 respectively. However, the discontinuation of diagnostic PESA is fraught with problems including liability to medico-legal sanctions. In study C, analysis of 177 treatment cycles involving PESA and ICSI revealed a successful sperm retrieval rate by PESA of 82% in the first cycle, 93% in the second, 96% in the third and 100% in the fourth cycle. The same trend was evident when sperm retrieval was examined in relation to each of the epididymides. Retrieved spermatozoa were found to be motile in 67-100% of cases and the frequency of samples containing motile spermatozoa did not decrease with increase in the number of PESA attempts. These results show that PESA does not jeopardize future epididymal sperm retrieval. In study D, the outcome of treatment with ICSI using ejaculated spermatozoa (305 cycles) (group D1) was compared with that of ICSI using spermatozoa obtained through PESA (54 cycles) (group D2). The median age of women in the two groups of couples was similar (34 years). In group D1, 70% of metaphase II oocytes were fertilized compared with 61% in group D2 (P < 0.01). The cleavage rate and the median numbers of transferred and cryopreserved embryos were similar in both groups. There was no significant difference between the clinical pregnancy rates (33 and 42% in groups D1 and D2 respectively). Our results show that the outcome of PESA-ICSI treatment compares favourably with that of ICSI using ejaculated spermatozoa.
利用1993年3月至1997年1月期间进行的经皮附睾精子抽吸术(PESA)和卵胞浆内单精子注射术(ICSI)的两组数据集开展了四项不同的研究。在研究A中,对181个PESA术后的ICSI治疗周期进行分析,结果显示附睾精子获取成功率为83%。这证实了PESA是一种有效的精子获取方法,与之相关的ICSI妊娠率(每次胚胎移植为35%)与其他精子获取方法相比具有优势。在研究B中,通过比较两组首次接受ICSI治疗周期且通过PESA获取精子的患者的精子获取率,确定了先前诊断性PESA程序的相关性。B1组(n = 50)在ICSI治疗周期的PESA程序之前进行了诊断性PESA,而B2组(n = 64)的患者则没有。B1组和B2组在治疗周期程序中的精子获取率分别为90%和82.8%,并无差异。然而,停止诊断性PESA存在诸多问题,包括可能面临医疗法律制裁。在研究C中,对177个涉及PESA和ICSI的治疗周期进行分析,结果显示PESA在第一个周期的精子获取成功率为82%,第二个周期为93%,第三个周期为96%,第四个周期为100%。当对每个附睾的精子获取情况进行检查时,也出现了同样的趋势。在67% - 100%的病例中发现获取的精子具有活力,且含有活动精子的样本频率并未随着PESA尝试次数的增加而降低。这些结果表明,PESA不会影响未来附睾精子的获取。在研究D中,比较了使用射出精子进行ICSI治疗的结果(305个周期)(D1组)与使用通过PESA获取的精子进行ICSI治疗的结果(54个周期)(D2组)。两组夫妻中女性的中位年龄相似(34岁)。在D1组中,70%的MII期卵母细胞受精,而D2组为61%(P < 0.01)。两组的卵裂率以及移植和冷冻保存胚胎的中位数相似。两组的临床妊娠率之间无显著差异(D1组和D2组分别为33%和42%)。我们的结果表明,PESA - ICSI治疗的结果与使用射出精子进行ICSI治疗的结果相比具有优势。